Biomarkers for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD): What is the Role of microRNAs?

Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2015, Vol 2, Issue 4

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous respiratory disease characterized by a progressive, not fully reversible airflow limitation associated with an abnormal inflammatory response of the lungs to noxious stimuli.1,2 Demographic data show that more than 200 million patients worldwide suffer COPD, leading the scientific community to speculate that in 2020 it will be the third important cause of mortality in the world.3 Several immune system cells (e.g. macrophages, eosinophils) and biochemical mediators (e.g. tumor necrosis factor-alpha, transforming growth factor beta, Interleukins and metalloproteases) are involved in its development and in symptoms severity.2

Authors and Affiliations

Luca Gallelli

Keywords

Related Articles

Pulmonary Rehabilitation in Multimorbidity and Multiple Disabilities

In Chronic Obstructive Pulmonary Disease (COPD) patients, it has been proven that Pulmonary Rehabilitation (PR) helps in increasing the exercise ability, in easing the difficulty in breathing, in improving Health-Related...

Tuberculosis and Pregnancy: An Updated Systematic Review

Tuberculosis (TB) affects women, especially in the child-bearing years. TB is associated with a poorer outcome of pregnancy, although this may be due to the general risk factors for TB, namely poverty, malnutrition and o...

Biomarkers for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD): What is the Role of microRNAs?

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous respiratory disease characterized by a progressive, not fully reversible airflow limitation associated with an abnormal inflammatory response of the lungs t...

The Importance of Rehabilitation before and after Lung Transplantation

Lung transplantation (LTx) has gained widespread acceptance as a therapeutic option for end-stage pulmonary disease. LTx has been shown to improve quality of life (QoL) and survival in individuals with various end-stage...

Pleural Diseases in Pregnancy: Aetiology and Management

Pleural diseases in pregnancy can cause considerable maternal and fetal morbidity and mortality. Some like pleural effusions may be small and pose like danger or massive causing significant respiratory compromise. Others...

Download PDF file
  • EP ID EP549977
  • DOI 10.17140/PRRMOJ-2-e002
  • Views 145
  • Downloads 0

How To Cite

Luca Gallelli (2015). Biomarkers for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD): What is the Role of microRNAs?. Pulmonary Research and Respiratory Medicine – Open Journal, 2(4), 3-5. https://europub.co.uk./articles/-A-549977